Investors

You heard it here first.

 
 
 

Our news

Bringing you the latest!

Investors

MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin

Corporate - Investors

6 April 2020

Publication of the activity report and financial information for the first half-year (April – Sept. 2019)

Investors

3 December 2019

 
 

CONTACT

  • This field is for validation purposes and should be left unchanged.